OnKure Therapeutics Files Form 4
Ticker: OKUR · Form: 4 · Filed: 2026-04-01T17:25:43-04:00
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
OnKure Therapeutics insider ownership changes filed 4/1/26.
AI Summary
On April 1, 2026, OnKure Therapeutics, Inc. filed a Form 4, reporting changes in beneficial ownership of securities. The filing date indicates transactions or events occurred on March 31, 2026. Liam Ratcliffe is listed as a reporting person associated with the company.
Why It Matters
Form 4 filings disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of ownership changes and does not inherently indicate increased risk.
Key Players & Entities
- OnKure Therapeutics, Inc. (company) — Issuer
- Liam Ratcliffe (person) — Reporting Person
- 2026-04-01 (date) — Filing Date
- 2026-03-31 (date) — Period of Report
FAQ
What type of filing is this?
This is a Form 4 - Statement of changes in beneficial ownership of securities.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-01 at 17:25:43.
Who is listed as a reporting person?
Liam Ratcliffe is listed as a reporting person.
What is the CIK for OnKure Therapeutics, Inc.?
The CIK for OnKure Therapeutics, Inc. is 0001637715.
What is the business address of OnKure Therapeutics, Inc.?
The business address is 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301.
From the Filing
EDGAR Filing Documents for 0001547100-26-000003 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001547100-26-000003 Filing Date 2026-04-01 Accepted 2026-04-01 17:25:43 Documents 1 Period of Report 2026-03-31 Document Format Files Seq Description Document Type Size 1 form4-04012026_090435.html 4 1 form4-04012026_090435.xml 4 4183 Complete submission text file 0001547100-26-000003.txt 5726 Mailing Address C/O ACCESS INDUSTRIES, INC 40 WEST 57TH ST, 28TH FLOOR NEW YORK NY 10019 Business Address Ratcliffe Liam ( Reporting ) CIK : 0001547100 (see all company filings) Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 26829558 Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892 OnKure Therapeutics, Inc. ( Issuer ) CIK : 0001637715 (see all company filings) EIN. : 472309515 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)